| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f452d84abea2c5cc44e1b41ea6798a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a3a26c9ebccb65330287374d856afaf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate |
2021-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992e579032f7ae9513e29155834ceac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae22556fd8d653a39e20a8d05eabf7be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed13f6c752ecf78c89a4a31b6614907f |
| publicationDate |
2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021224198-A1 |
| titleOfInvention |
Mifepristone oral form for its use in cervix ripening and labour induction |
| abstract |
The invention relates to an oral dosage form of mifepristone of mifepristone oral formulation characterised in that said formulation comprises an amount selected from the group consisting of 75mg, 150 mg or 300 mg mifepristone, and said formulation is for its use in the cervix ripening and induction of labour in a woman being at least 37 weeks pregnant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1028284-B1 |
| priorityDate |
2020-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |